Cansino Biologics Inc.

This study tests a vaccine that protects against four types of meningococcal bacteria that cause meningitis, a serious brain infection. It involves 660 children aged 6 to 23 months who receive two doses of the vaccine. Researchers check how well the vaccine triggers the immune sy…